Skip to content
Extreme Investor Network
  • Contact Us
  • Privacy Policy

wall street journal

Our #1 Biotech Stock for April

April 21, 2022April 1, 2022
Biotech Stocks

On September 10, 2018, a tiny Cambridge biotech firm won a patent on a new kind of genetic software that can “Cut & Paste” any disease from your body. This revolutionary new kind of treatment … Read more

Categories Stocks, Bonds, and Trading Tags biotech stock, genetic disease, investors, wall street journal

Categories

Recent Posts

  • Tracking Your Federal Tax Refund: A Guide to Checking Its StatusFebruary 5, 2025
  • Cramer’s Lightning Round: Avoid Investing in BitdeerFebruary 5, 2025
  • Sui Basecamp 2025: Upcoming Blockchain Event in DubaiFebruary 5, 2025
  • Mark Zuckerberg’s Wealth Soars by $40 Billion Amidst Meta’s Success SurgeFebruary 5, 2025
  • Gold Price Outlook: Rally Continues, but Overbought Indicators Suggest Potential PullbackFebruary 5, 2025
  • Stocks with the Largest After-Hours Moves: QCOM, F, ARMFebruary 5, 2025
  • Trump’s China Tariffs to Impact Ford, GM Vehicles and Auto ComponentsFebruary 5, 2025
  • Fed Officials Express Worries Over Trump’s Tariffs and Inflation IssuesFebruary 5, 2025
  • BlackRock Launches New ETFs Targeting $6 Trillion Money Market SectorFebruary 5, 2025
  • A ‘Set-It-and-Forget-It’ Investment Strategy Might Underperform in 2025February 5, 2025

Archives

© 2025 Extreme Investor Network

Usermaven | Website analytics and product insights